Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 04, 2017
Bruker has announced the acquisition of InVivo Biotech Services GmbH, headquartered in Hennigsdorf, Germany, near Berlin. InVivo Biotech is a molecular biology contract manufacturing organization (CMO), and a leading provider of monoclonal antibodies...
read more
Alcami, a provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, will expand service capabilities at its Charleston, SC, Edison, NJ, St. Louis, MO, and Wilmington, NC sites to offer ...
read more
Wednesday, March 15, 2017
Callery, LLC is the new stand-alone entity formed from BASF's divestment of its Inorganic Specialties business. The divestiture was facilitated by Edgewater Capital in combination with the Callery management team. Callery is a global leader in highly...
read more
Wednesday, October 05, 2022
Almac Clinical Services announced a new state-of-the-art Cryogenic Service Solution within its Durham, North Carolina campus to support cell and gene therapies.
read more
Wednesday, January 03, 2018
BrainStorm Cell Therapeutics has received GMP approval from the Israel Ministry of Health for its Israeli contract manufacturing facility.
read more
Strata has signed an agreement with BioMed to accelerate patient identification and enrollment for BioMed Valley's Phase 2 study of BVD-523 for advanced malignancies harboring MEK or atypical BRAF alterations.
read more
Biologics, Inc. has been selected by AstraZeneca as a specialty pharmacy provider for IRESSA® (gefitinib). IRESSA® was approved by the FDA on July 13, 2015, for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC).
read more
Wednesday, September 16, 2015
The ALS Association announced that a critical effort made possible by the ALS Ice Bucket Challenge is underway, involving nearly 100 people with ALS and caregivers, researchers, clinicians, and industry experts from across the country to create drug ...
read more
SPT Labtech, a laboratory automation solutions company for the life sciences industry, announced that David Newble has been appointed CEO, stepping up from his previous position as Managing Director. In his new capacity, he takes responsibility for ...
read more
Orientation Marketing, a pharmaceutical and life science marketing agency, opened a new office in Espoo, Finland to serve its growing client base in the Nordic and EU regions.
read more
Rentschler Biopharma has entered into a collaboration with Genmab for the development and manufacture of bispecific antibodies generated with Genmab’s DuoBody technology platform.
read more
AmerisourceBergen has become the first pharmaceutical 3PL provider to achieve certification under the ISO 9001:2015 standards.
read more
Wednesday, August 30, 2017
Avista Pharma Solutions announced Eric Evans has been named its Chief Financial Officer effective August 28, 2017.
read more
SCHOTT Pharma plans to make Wilson, North Carolina home to its newest site. The investment is supported by $21 million in state and local incentive awards and will expand SCHOTT Group’s presence in the United States, a strategic market in its growth ...
read more
Monday, September 29, 2025
Informa Markets announced the shortlist for the CPHI Pharma Awards 2025, recognizing outstanding achievements across pharmaceutical innovation, manufacturing, sustainability, leadership and women in pharma.
read more